Piyush Rathi

ALL
News
Opinion
Photos
Videos

Jump to

Advanced Enzyme's target for FY17: 100% capacity utilisation

VL Rathi, Promoter Director, Advanced Enzyme Technologies is confident of maintaining margins at around 40 percent for FY17.
Promoters will hold 66% in co post IPO: Advanced Enzyme

In an interview of CNBC-TV18, Chandrakant Rathi, Promoter & MD and Piyush Rathi, CMO of Advanced Enzyme Technologies spoke about their initial public offering (IPO) which hits the market today.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Piyush Rathi

Advanced Enzyme's target for FY17: 100% capacity utilisation

Promoters will hold 66% in co post IPO: Advanced Enzyme